PubMed ID:
36586772
Public Release Type:
Journal
Publication Year: 2023
Affiliation: Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; AdventHealth Translational Research Institute, Orlando, 32804, USA. Electronic address: daria.igudesman@adventhealth.com.; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.; AdventHealth Translational Research Institute, Orlando, 32804, USA.; Department of Pediatrics, Division of Endocrinology, Stanford University, Stanford, 94304, USA.; Department of Pediatrics, Division of Endocrinology, Stanford University, Stanford, 94304, USA.; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.; AdventHealth Translational Research Institute, Orlando, 32804, USA.; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.; Department of Pediatrics, Division of Endocrinology, Stanford University, Stanford, 94304, USA.; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.; Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA.
DOI:
https://doi.org/10.1016/j.numecd.2022.11.017
Authors:
Igudesman Daria, Crandell Jamie, Corbin Karen D, Zaharieva Dessi P, Addala Ananta, Thomas Joan M, Bulik Cynthia M, Pence Brian W, Pratley Richard E, Kosorok Michael R, Maahs David M, Carroll Ian M, Mayer-Davis Elizabeth J
Request IDs:
21135
Studies:
Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications
Disordered eating (DE) in type 1 diabetes (T1D) includes insulin restriction for weight loss with serious complications. Gut microbiota-derived short chain fatty acids (SCFA) may benefit host metabolism but are reduced in T1D. We evaluated the hypothesis that DE and insulin restriction were associated with reduced SCFA-producing gut microbes, SCFA, and intestinal microbial diversity in adults with T1D.